1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

The Rebate Rule May Not Last, But It Changed The Pricing Debate

 
• By Cole Werble

Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.

If only resolving the drug pricing debate were this simple • Source: Shutterstock

Of all the 11th hour attempts to finalize drug pricing policy changes by the outgoing Trump Administration, a final rule eliminating rebates in the US Medicare outpatient drug program (Part D) is both the easiest and most certain to be blocked by the new Biden Administration.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access